High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults

Summary

This study examines an intervention to promote effective, evidence-based care and de-implement inappropriate therapies for COPD in HIV-infected (HIV+) patients. The intervention facilitates specialist support of primary care, which includes infectious disease (ID) physicians who serve as the primary care providers (PCP) for their HIV+ patients in the ID clinic. Rather than relying on referral-driven specialty care which may be a barrier to access, pulmonologists will proactively support ID providers to manage a population of HIV+ patients with COPD, delivering real-time evidence-based recommendations tailored to the individual HIV+ patient in the form of an E-consult.

Conditions

• COPD
• HIV/AIDS

Interventions

BEHAVIORAL

Proactive E-consult

E-consult recommendations and orders will be developed by a panel of pulmonologists and will address a range of care elements for patients with COPD.

Sponsors & Collaborators

• VA Puget Sound Health Care System

  collaborator FED

• Washington D.C. Veterans Affairs Medical Center

  collaborator FED

• VA Eastern Colorado Health Care System

  collaborator FED

• University of Colorado, Denver

  collaborator OTHER

• VA Greater Los Angeles Healthcare System

  collaborator FED

• Atlanta VA Medical Center

  collaborator FED

• Yale University

  collaborator OTHER

• VA Connecticut Healthcare System

  collaborator FED

• Corporal Michael J. Crescenz VA Medical Center

  collaborator FED

• VA Tennessee Valley Health Care System

  collaborator FED

• Seattle Institute for Biomedical and Clinical Research

  lead OTHER

Principal Investigators

• David H. Au, MD, MS · VA Puget Sound Health Care System

• Kristina A. Crothers, MD · VA Puget Sound Health Care System

• Christian D. Helfrich, PhD, MPH · VA Puget Sound Health Care System

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

89 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2019-05-21

Primary Completion

2025-05-31

Completion

2025-05-31

Countries

• United States

Study Locations